APP and schizophrenia: Thus, a Cochrane review of sixty-two randomized studies comparing APP with antipsychotic monotherapy for the treatment of schizophrenia and/or schizophrenia-like psychoses found “very low-quality evidence that a combination of antipsychotics may improve the clinical response“ [8].